EVAR; FDG PET; abdominal aortic aneurysm; cancer; endovascular aortic repair; survival; General Medicine
Abstract :
[en] Background: Abdominal aortic aneurysm (AAA) is a chronic inflammatory disease that poses several challenges. Given the increasing evidence that AAA patients are more likely to develop cancer and the importance of its early detection, we strived to develop a non-invasive tool based on serial FDG-PET/CT scan examinations to identify, among AAA patients, those at risk of cancer. Methods: Between 2006 and 2011 we recruited 149 AAA patients, free of cancer at baseline, and followed them until the end of 2021. All patients underwent an FDG-PET/CT scan at inclusion and possibly more scans during follow-up. At each medical imaging examination, the aneurysmal FDG uptake was recorded. Patients were stratified based on their aortic wall PET status (negative/positive). Any occurrence of cancer was reported. A Cox regression analysis and competing-risk modeling were applied to the data. Results: The proportion of AAA patients who developed cancer was 31.5% (mean time to diagnosis was 5.7 ± 3.4 years) and the death rate was 59%. A difference in cancer incidence between PET+ and PET- patients was detected (46.8% vs. 27.3%; HR = 1.96, 95%CI: 1.07-3.57, p = 0.028). Moreover, AAA patients undergoing surgical treatment had a lower risk of cancer than unoperated patients (28% vs. 50%; HR = 0.41, 95%CI: 0.21-0.80, p = 0.009). Conclusions: In AAA patients, diagnostic imaging with an FDG-PET/CT scan can help identify those patients at a higher risk of developing cancer. Moreover, the higher cancer risk in non-surgically treated patients calls for further analysis of associations between aneurysm growth and malignant disease.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Sakalihasan, Natzi ; Université de Liège - ULiège > Département des sciences cliniques
Sakalihasan N. Michel J.-B. Katsargyris A. Kuivaniemi H. Defraigne J.-O. Nchimi A. Powell J.T. Yoshimura K. Hultgren R. Abdominal Aortic Aneurysms Nat. Rev. Dis. Primers 2018 4 34 10.1038/s41572-018-0030-7 30337540
Dyba T. Randi G. Bray F. Martos C. Giusti F. Nicholson N. Gavin A. Flego M. Neamtiu L. Dimitrova N. et al. The European Cancer Burden in 2020: Incidence and Mortality Estimates for 40 Countries and 25 Major Cancers Eur. J. Cancer 2021 157 308 347 10.1016/j.ejca.2021.07.039 34560371
Maiorino L. Daßler-Plenker J. Sun L. Egeblad M. Innate Immunity and Cancer Pathophysiology Annu. Rev. Pathol. 2022 17 425 457 10.1146/annurev-pathmechdis-032221-115501 34788549
Lega I.C. Lipscombe L.L. Review: Diabetes, Obesity, and Cancer-Pathophysiology and Clinical Implications Endocr. Rev. 2020 41 bnz014 10.1210/endrev/bnz014 31722374
Lüscher T.F. Cardio-Oncology: A New Specialty Moves to Centre Stage Eur. Heart J. 2019 40 1743 1746 10.1093/eurheartj/ehz368 33215651
Blaes A.H. Shenoy C. Is It Time to Include Cancer in Cardiovascular Risk Prediction Tools? Lancet 2019 394 986 988 10.1016/S0140-6736(19)31886-0 31443925
Handy C.E. Quispe R. Pinto X. Blaha M.J. Blumenthal R.S. Michos E.D. Lima J.A.C. Guallar E. Ryu S. Cho J. et al. Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment: Together We Are Stronger Circulation 2018 138 727 734 10.1161/CIRCULATIONAHA.118.035516
Sundbøll J. Veres K. Horváth-Puhó E. Adelborg K. Sørensen H.T. Risk and Prognosis of Cancer after Lower Limb Arterial Thrombosis Circulation 2018 138 669 677 10.1161/CIRCULATIONAHA.117.032617
Banke A. Schou M. Videbaek L. Møller J.E. Torp-Pedersen C. Gustafsson F. Dahl J.S. Køber L. Hildebrandt P.R. Gislason G.H. Incidence of Cancer in Patients with Chronic Heart Failure: A Long-Term Follow-up Study Eur. J. Heart Fail. 2016 18 260 266 10.1002/ejhf.472
Meijers W.C. Maglione M. Bakker S.J.L. Oberhuber R. Kieneker L.M. de Jong S. Haubner B.J. Nagengast W.B. Lyon A.R. van der Vegt B. et al. Heart Failure Stimulates Tumor Growth by Circulating Factors Circulation 2018 138 678 691 10.1161/CIRCULATIONAHA.117.030816
Bertero E. Canepa M. Maack C. Ameri P. Linking Heart Failure to Cancer: Background Evidence and Research Perspectives Circulation 2018 138 735 742 10.1161/CIRCULATIONAHA.118.033603 30359132
Szilagyi D.E. Elliott J.P. Berguer R. Coincidental Malignancy and Abdominal Aortic Aneurysm. Problems of Management Arch. Surg. 1967 95 402 412 10.1001/archsurg.1967.01330150078012 6035464
Tilson M.D. Fieg E.L. Harvey M. Malignant Neoplasia in Patients with Abdominal Aortic Aneurysms Arch. Surg. 1984 119 792 794 10.1001/archsurg.1984.01390190036008 6732490
Schermerhorn M.L. Buck D.B. O’Malley A.J. Curran T. McCallum J.C. Darling J. Landon B.E. Long-Term Outcomes of Abdominal Aortic Aneurysm in the Medicare Population N. Engl. J. Med. 2015 373 328 338 10.1056/NEJMoa1405778 26200979
Sakalihasan N. Van Damme H. Gomez P. Rigo P. Lapiere C.M. Nusgens B. Limet R. Positron Emission Tomography (PET) Evaluation of Abdominal Aortic Aneurysm (AAA) Eur. J. Vasc. Endovasc. Surg. 2002 23 431 436 10.1053/ejvs.2002.1646
Truijers M. Kurvers H.A.J.M. Bredie S.J.H. Oyen W.J.G. Blankensteijn J.D. In Vivo Imaging of Abdominal Aortic Aneurysms: Increased FDG Uptake Suggests Inflammation in the Aneurysm Wall J. Endovasc. Ther. 2008 15 462 467 10.1583/08-2447.1
Sarda-Mantel L. Coutard M. Rouzet F. Raguin O. Vrigneaud J.-M. Hervatin F. Martet G. Touat Z. Merlet P. Le Guludec D. et al. 99mTc-Annexin-V Functional Imaging of Luminal Thrombus Activity in Abdominal Aortic Aneurysms Arterioscler. Thromb. Vasc. Biol. 2006 26 2153 2159 10.1161/01.ATV.0000237605.25666.13
Defawe O.D. Hustinx R. Defraigne J.O. Limet R. Sakalihasan N. Distribution of F-18 Fluorodeoxyglucose (F-18 FDG) in Abdominal Aortic Aneurysm: High Accumulation in Macrophages Seen on PET Imaging and Immunohistology Clin. Nucl. Med. 2005 30 340 341 10.1097/01.rlu.0000159681.24833.95
Kotze C.W. Menezes L.J. Endozo R. Groves A.M. Ell P.J. Yusuf S.W. Increased Metabolic Activity in Abdominal Aortic Aneurysm Detected by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Eur. J. Vasc. Endovasc. Surg. 2009 38 93 99 10.1016/j.ejvs.2008.12.016
Marini C. Morbelli S. Armonino R. Spinella G. Riondato M. Massollo M. Sarocchi F. Pane B. Augeri C. Abete L. et al. Direct Relationship between Cell Density and FDG Uptake in Asymptomatic Aortic Aneurysm Close to Surgical Threshold: An in Vivo and in Vitro Study Eur. J. Nucl. Med. Mol. Imaging 2012 39 91 101 10.1007/s00259-011-1955-1
Courtois A. Nusgens B.V. Hustinx R. Namur G. Gomez P. Somja J. Defraigne J.-O. Delvenne P. Michel J.-B. Colige A.C. et al. 18F-FDG Uptake Assessed by PET/CT in Abdominal Aortic Aneurysms Is Associated with Cellular and Molecular Alterations Prefacing Wall Deterioration and Rupture J. Nucl. Med. 2013 54 1740 1747 10.2967/jnumed.112.115873
Reeps C. Bundschuh R.A. Pellisek J. Herz M. van Marwick S. Schwaiger M. Eckstein H.-H. Nekolla S.G. Essler M. Quantitative Assessment of Glucose Metabolism in the Vessel Wall of Abdominal Aortic Aneurysms: Correlation with Histology and Role of Partial Volume Correction Int. J. Cardiovasc. Imaging 2013 29 505 512 10.1007/s10554-012-0090-9 22772434
Jalalzadeh H. Indrakusuma R. Planken R.N. Legemate D.A. Koelemay M.J.W. Balm R. Inflammation as a Predictor of Abdominal Aortic Aneurysm Growth and Rupture: A Systematic Review of Imaging Biomarkers Eur. J. Vasc. Endovasc. Surg. 2016 52 333 342 10.1016/j.ejvs.2016.05.002 27283346
Barwick T.D. Lyons O.T.A. Mikhaeel N.G. Waltham M. O’Doherty M.J. 18F-FDG PET-CT Uptake Is a Feature of Both Normal Diameter and Aneurysmal Aortic Wall and Is Not Related to Aneurysm Size Eur. J. Nucl. Med. Mol. Imaging 2014 41 2310 2318 10.1007/s00259-014-2865-9
Palombo D. Morbelli S. Spinella G. Pane B. Marini C. Rousas N. Massollo M. Cittadini G. Camellino D. Sambuceti G. A Positron Emission Tomography/Computed Tomography (PET/CT) Evaluation of Asymptomatic Abdominal Aortic Aneurysms: Another Point of View Ann. Vasc. Surg. 2012 26 491 499 10.1016/j.avsg.2011.05.038 22197524
Tegler G. Ericson K. Sörensen J. Björck M. Wanhainen A. Inflammation in the Walls of Asymptomatic Abdominal Aortic Aneurysms Is Not Associated with Increased Metabolic Activity Detectable by 18-Fluorodeoxglucose Positron-Emission Tomography J. Vasc. Surg. 2012 56 802 807 10.1016/j.jvs.2012.02.024 22854268
Courtois A. Nusgens B. Garbacki N. Hustinx R. Gomez P. Defraigne J.-O. Colige A.C. Sakalihasan N. Circulating microRNAs Signature Correlates with Positive [18F]Fluorodeoxyglucose-Positron Emission Tomography in Patients with Abdominal Aortic Aneurysm J. Vasc. Surg. 2018 67 585 595.e3 10.1016/j.jvs.2016.12.112 28431866
Courtois A. Makrygiannis G. El Hachemi M. Hultgren R. Allaire E. Namur G. Hustinx R. Defraigne J.-O. Sakalihasan N. Positron Emission Tomography/Computed Tomography Predicts and Detects Complications After Endovascular Repair of Abdominal Aortic Aneurysms J. Endovasc. Ther. 2019 26 520 528 10.1177/1526602819849088 31074323
Zhang Z. Reinikainen J. Adeleke K.A. Pieterse M.E. Groothuis-Oudshoorn C.G.M. Time-Varying Covariates and Coefficients in Cox Regression Models Ann. Transl. Med. 2018 6 121 10.21037/atm.2018.02.12
Reeps C. Essler M. Pelisek J. Seidl S. Eckstein H.-H. Krause B.-J. Increased 18F-Fluorodeoxyglucose Uptake in Abdominal Aortic Aneurysms in Positron Emission/Computed Tomography Is Associated with Inflammation, Aortic Wall Instability, and Acute Symptoms J. Vasc. Surg. 2008 48 417 423 10.1016/j.jvs.2008.03.059
Hussain S.P. Harris C.C. Inflammation and Cancer: An Ancient Link with Novel Potentials Int. J. Cancer 2007 121 2373 2380 10.1002/ijc.23173 17893866
Courtois A. Nusgens B.V. Hustinx R. Namur G. Gomez P. Kuivaniemi H. Defraigne J.-O. Colige A.C. Sakalihasan N. Gene Expression Study in Positron Emission Tomography-Positive Abdominal Aortic Aneurysms Identifies CCL18 as a Potential Biomarker for Rupture Risk Mol. Med. 2015 20 697 706 10.2119/molmed.2014.00065
Treska V. Kocova J. Boudova L. Neprasova P. Topolcan O. Pecen L. Tonar Z. Inflammation in the Wall of Abdominal Aortic Aneurysm and Its Role in the Symptomatology of Aneurysm Cytokines Cell Mol. Ther. 2002 7 91 97 10.1080/13684730310001652
Egeblad M. Werb Z. New Functions for the Matrix Metalloproteinases in Cancer Progression Nat. Rev. Cancer 2002 2 161 174 10.1038/nrc745
Germolec D.R. Shipkowski K.A. Frawley R.P. Evans E. Markers of Inflammation Methods Mol. Biol. 2018 1803 57 79 10.1007/978-1-4939-8549-4_5 29882133
Ahn S. Min J.-Y. Kim H.G. Mo H. Min S.-K. Min S. Ha J. Min K.-B. Outcomes after Aortic Aneurysm Repair in Patients with History of Cancer: A Nationwide Dataset Analysis BMC Surg. 2020 20 85 10.1186/s12893-020-00754-3 32357930
